This paper examines some of the problems specifically associated with conducting research into acupuncture and how this can lead to further problems with subsequent systematic reviews. Studies for the treatment of chronic neck pain have been used as examples of how presented information can be misleading to an acupuncture-naive reader and how researchers must be sensitive to these problems when compiling their inclusion and exclusion criteria. The problems associated with scoring trials are discussed and further work to increase the scope of scoring mechanisms is recommended in order to produce meaningful systematic reviews in the future. The efficacy of the treatment of chronic mechanical neck pain with acupuncture has yet to be convincingly proven. The prime reason for this is the lack of basic evidence, in the form of good-quality randomized controlled trials (RCTs). Adding to the confusion is a plethora of systematic reviews on acupuncture and pain that have included a number of clinical trials on the use of acupuncture to treat neck pain, some of which should have perhaps been omitted, either because they did not involve acupuncture or because they are of such poor quality that they tell us little that is constructive about its clinical effects. Systematic reviews can be a very valuable tool because they can give an indication of the quality of trials and also form a summary of the available literature on a particular subject. In this format, evidence is easily accessible and digestible to researchers and, perhaps more importantly, to clinicians and purchasers, who often simply require a reliable summary of evidence in order to make policy or informed clinical decisions. The aim of all clinical research must surely be to assess an intervention or process or the relationship between variables, ultimately in order to be able to improve clinical practice and health-care for patientsuconsumers. As such, evidence gathered must have external validity (generalizability) w1x and it must be relevant to clinical practice. This article examines some of the fundamental pitfalls in which some of these systematic reviews have been caught, thus raising issues about their credibility, generalizability and subsequent conclusions. Our aim is to critically review the foundations of systematic reviews within the field of acupuncture with particular reference to neck pain, and to open up a debate that will allow us to formulate new and more appropriate methodology.
The efficacy of the treatment of chronic mechanical neck pain with acupuncture has yet to be convincingly proven. The prime reason for this is the lack of basic evidence, in the form of good-quality randomized controlled trials (RCTs). Adding to the confusion is a plethora of systematic reviews on acupuncture and pain that have included a number of clinical trials on the use of acupuncture to treat neck pain, some of which should have perhaps been omitted, either because they did not involve acupuncture or because they are of such poor quality that they tell us little that is constructive about its clinical effects. Systematic reviews can be a very valuable tool because they can give an indication of the quality of trials and also form a summary of the available literature on a particular subject. In this format, evidence is easily accessible and digestible to researchers and, perhaps more importantly, to clinicians and purchasers, who often simply require a reliable summary of evidence in order to make policy or informed clinical decisions. The aim of all clinical research must surely be to assess an intervention or process or the relationship between variables, ultimately in order to be able to improve clinical practice and health-care for patientsuconsumers. As such, evidence gathered must have external validity (generalizability) w1x and it must be relevant to clinical practice. This article examines some of the fundamental pitfalls in which some of these systematic reviews have been caught, thus raising issues about their credibility, generalizability and subsequent conclusions. Our aim is to critically review the foundations of systematic reviews within the field of acupuncture with particular reference to neck pain, and to open up a debate that will allow us to formulate new and more appropriate methodology.
There have been many systematic reviews which have included trials relating to the efficacy of acupuncture for the treatment of neck pain along with other trials involving painful conditions w2-11x. The broad general conclusions of these are summarized in Table 1 .
With many of these trials being examined over and over again by so many investigators, we must ask why there is a need to revisit this topic. Why must we scrutinize the results of these reviews with scepticism and why does the answer to the acupuncture and neck pain conundrum remain so elusive? The answer to these questions may lie, in part, with the quality and number of RCTs as well as the systematic review methodology and the subsequent selection and analysis of these trials.
Only one review has attempted to deal solely with the question of acupuncture and neck pain. This was carried out by White and Ernst w9x. As our particular interest was in neck pain, their review will be, by way of example, the focus of this article. However, we concentrate on the science involved in systematic reviews. It must be pointed out that both White and Ernst are well-respected and thoughtful investigators in the field of complementary medicine, being both prolific and thorough in their work. This paper therefore highlights the fact that systematic reviews can be difficult, as even the most diligent and seasoned of researchers can fall foul of the inherent pitfalls.
Literature search
In order to provide an unbiased report of the current literature available, the literature search must be exhaustive and include all relevant trials, including the grey literature (i.e. unpublished studies or studies published in non-Medline journals). However within the field of acupuncture there may be some bias, which could confound the outcome. Vickers et al. w12x produced a review that examined the results of acupuncture RCTs published in different countries. They examined a total of 252 trials from 27 countries between 1966 and 1995 and found that 10 countries produced only positive results in the published literature. The most prolific producer of trials that fit the criteria used by Vickers et al. was the USA, with 47 trials, 53% of which showed a positive outcome. Second in the list was China, with 36 published trials, 100% of which showed positive results. They noted that RussiauUSSR also had a high positive publication rate, 10 out of 11 trials (91%) being positive. The trials from East Asia and Eastern Europe as a whole tended to show only positive results. This indicates a clear publication bias by country and therefore we must take this into account in our interpretation of the outcome of any systematic review. 
Inclusionuexclusion criteria
The subject to be reviewed must be clearly stated and trials that are included in a systematic review must be appropriate to the subject being examined. This implies the use of great clarity and rigour with respect to the inclusion and exclusion criteria.
White and Ernst did indeed have a clear research agenda, i.e. to 'summarise the existing evidence for or against the hypothesis that acupuncture is an efficacious therapy for neck pain'. Their inclusion criteria for neck pain trials were that they had to be randomized and controlled, and they had to use used acupuncture, electro-acupuncture or lasers over acupuncture points. Their search revealed only 32 possibly relevant trials, 18 of which were excluded for various reasons, e.g. non-randomization or no control group. This left 14 trials, which White and Ernst scored using the 0-5 Jadad scoring system (see below). Those scoring two or less (poor quality) were: Junnila w18x, Loy w19x, Petrie and Langley w20x, Petrie and Hazleman w21x, Kisiel and Lindh w22x, David et al. w23x and Irnich et al. w24x (this trial was unpublished when included in the systematic review). The higher-scoring studies are summarized in Table 2 (adapted from White and Ernst w9x).
This raises several issues in interpreting the trial data in relation to the primary aim of this systematic review. The inclusion of lasers is curious as this does not involve the use of needles and is therefore not acupuncture. It would seem reasonable, when specifically purporting to be examining acupuncture efficacy, to only include trials that actually used acupuncture, i.e. needle 
Mendelson w2x
Some evidence that acupuncture has a marked analgesic effect Richardson w3x
Generally, 50-80% of patients receive benefit from acupuncture Patel w4x
Pooled results showed significance in favour of acupuncture ter Riet w5x
The efficacy of acupuncture for chronic pain remains doubtful Aker w6x
Lack of evidence for many conservative treatments of neck pain Ernst w7x
In the main, acupuncture is not superior to sham needling Kjellman w8x
Few trials on neck problems are of high methodological quality White w9x
Acupuncture treatment for neck pain is not supported by evidence Smith w10x
No convincing evidence for acupuncture for back or neck pain Ezzo w11x
Inconclusive proof that acupuncture is more effective than placebo puncture, as a treatment. The logic behind including forms of treatment other than acupuncture is questionable. Cummings w25x pointed out that, to combine studies that use an active and invasive treatment, such as needling, with others in which the intervention is imperceptible, such as laser treatment, is 'clearly a mistake'. This is particularly pertinent when including an entirely unproven treatment, such as laser treatment, which, if it is specifically effective, may be mobilizing an entirely different neurological and neurohumoural mechanism from that activated by acupuncture. White and Ernst later justified their inclusion of laser therapy by suggesting that 'laser is used as therapy and patients need to know if there is evidence that it is effective' w17x.
Patients do indeed need to know about this form of therapy. However, they also need to know about the use of ultrasound, pulsed electromagnetic energy, cervical collars and a host of other interventions, but there would similarly be little justification or value in including trials on these subjects in a review of acupuncture. The studies by Kreczi and Klingler w26x and the trial by Ceccherelli et al. w27x both only used laser to acupuncture points and therefore should also be excluded. This reduces the number of reviewable trials to 12. The systematic review of Smith et al. w10x also included laser treatment, in our view incorrectly, whereas ter Riet et al. w5x and Ezzo et al. w11x deliberately excluded this type of treatment.
As efficacy may vary from condition to condition w28, 29x, it may well be very prudent to limit reviews to one specific painful site or pathology. White and Ernst w9x rightly excluded two trials because there was pain in multiple sites. However, of the 14 trials that were included in the review, four should not have been because they involved neck anduor back pain-Gallacchi et al. w30x, Junnila w18x, Emery and Lythgoe w31x and Kreczi and Klingler w26x; three of these attained higher Jadad scores in White and Ernst's review. If the authors' stated exclusion criteria had been followed, a further three trials would also have been excluded, leaving nine. Ezzo et al. w11x, in their review of chronic pain, similarly combined multiple diagnoses and pain from multiple sites. Whilst this would appear to be a reasonable step if specifically looking at chronic pain, it does not further illuminate the question of efficacy if acupuncture is indeed condition-specific. Patel et al. w4x, however, whilst still examining acupuncture for chronic pain in general, actually split specific conditions into discrete subgroups, thereby enabling separate analysis. Similarly, there might also be some value in analysing trials separately according to follow-up period, i.e. the acute effects of acupuncture might be different from the longer-term effects, and this might have repercussions on the results of a systematic review.
Treatment
The type of treatment given is vitally important and must be such that it can be considered adequate by general consensus of those who use acupuncture. The question of what is adequate is, of course, a matter for debate and may vary widely from practitioner to practitioner, but this important problem needs to be addressed. A method for developing treatment protocols, the 'BRITS' method, has been suggested as a way forward for improving the quality of treatment in acupuncture trials w32x. It recommends, among other things, a comprehensive review of the literature in order to ascertain an optimum consensus about the treatment protocol. Clearly, trials with too few treatment sessions, too few needles and an unusual or unacceptable needling technique must be considered suboptimal; this might be analogous to treating an infection with one small dose of an inappropriate antibiotic. As Birch w33x stated, 'a clinical trial will be a fair test of acupuncture only if an adequate treatment is administered'. If the number of needles used is too few, this could seriously impair efficacy, as often the combination of acupuncture points used may give a much more powerful effect than each point used individually w34x. It is also thought that acupuncture may have a cumulative effect w11, 35x; if this is so, treatment regimes must reflect clinical practice if we are to arrive at a realistic evaluation of its clinical 
a 'Formula' indicates that specific, preset acupuncture points were used, whereas 'classical' suggests a much more flexible approach, as in traditional Chinese acupuncture. b 'Sham' indicates needling at non-acupuncture points; 'dummy needling' refers to some form of 'staged' acupuncture in which no penetration occurred; 'superficial needling' suggests minor penetration (usually 2-3 mm) at acupuncture sites.
effects. Ironically, White and Ernst in an earlier paper w36x stated that 'It is important to examine the adequacy of acupuncture treatments to correctly assess studies in the field and to develop improved protocols for future research'.
Indeed
This further reduces the number of admissible trials to four. Whilst many of the reviews that included neck pain trials (Table 1 ) noted the specific treatment given, no author made an analysis of the adequacy of the treatment or excluded trials on the grounds of poor treatment. Ter Riet et al. w5x, in their scoring system, included a section entitled 'Adequacy of treatment'. However, this related to an inclusion of the description of treatment given rather than its adequacy as a therapy. Ezzo et al. w11x commented that 'issues of dosing and an adequateuoptimal acupuncture procedure need to be examined' but unfortunately failed to do this in their systematic review. Patel et al. w4x suggested that the choice between formula and classical traditional Chinese acupuncture may influence the outcome, but failed to make detailed comment on this in his systematic review. This also highlights a problem relating to the experience of the investigator. If a trial or systematic review is undertaken, it is imperative that the investigator has a good working knowledge of the complexities of the treatment regime used so that informed and logical decisions can be made as to its adequacy and therefore external validity. It is also vital, therefore, that a clear methodology for evaluating treatment adequacy is developed and incorporated into further systematic reviews of acupuncture w41x. Such standards must be developed strictly in consultation with the field, and should recognize the different modes of practice used in the studies under review.
Controls
The choice of control is important as this enables different questions to be answered. It is felt that if the question to be answered relates to the specific efficacy of acupuncture vs placebo or inactive treatment, it would be reasonable to exclude trials which used an active control as this may trigger analgesic mechanisms, such as diffuse noxious inhibitory control (DNIC) w42, 43x. This implies that sham acupuncture may not be an appropriate placeboucontrol w44x to determine the specific efficacy of acupuncture in the context of an RCT. Once again, returning to the White and Ernst review w9x, the trial by Gallacchi et al. w30x used sham acupuncture as the control whereas Lundeberg et al. w38x and Thomas et al. w39x used superficial acupuncture, which, it could be argued, might still have a physiological effect w45x through the mechanism of DNIC. Loy w19x, Kisiel and Lindh w22x and David et al. w23x all used an alternative but active treatment, i.e. physiotherapy. Lastly, the trial by Coan et al. w40x used a waiting list control and therefore did not control for non-specific effects. Of the original 14 trials therefore included in this systematic review, only two, i.e. Petrie and Langley w20x and Petrie and Hazleman w21x, were appropriate for inclusion in order to answer the question posed. We feel that two studies are insufficient to conduct a meaningful systematic review. These two trials incidentally provide contradictory evidence as to the efficacy of acupuncture for the treatment of neck pain.
The nature and format of a study to be reviewed must also be taken into account and the wisdom of including it must be examined when attempting to answer a specific question relating to efficacy. Three of the 14 trials included by White and Ernst employed a crossover design. Whilst this in itself is not a flaw, it is not known whether the effects (if any) of acupuncture are shortlived or more long-term. In a crossover study there may therefore be problems with cross-contamination of results due to carry-over. A washout period of several months may be appropriate to negate any such possible effect w44, 46x, and therefore the inclusion and subsequent interpretation of crossover trials must be accompanied by guarded and cautious conclusions. Interestingly, Smith et al. w10x circumvented this problem in their systematic review by only considering data from the first treatment period where a crossover trial was used.
Scoring
It is useful to assign scores to trials in order to ascertain their relative credibility and assess their methodological competence. Failure to consider trial quality may certainly introduce bias into the results of any pooled analysis w47x, and if the prime studies are flawed then any conclusions drawn by a meta-analysis will be invalid w48x. However, if this is to have any real meaning, the trials must be homogeneous and therefore comparable, and the scoring system must be relevant to the pragmatic clinical practice of acupuncture as well as to the carefully defined rigorous science of an RCT. The 14 studies reviewed by White and Ernst were scored using a modified (and therefore unvalidated) Jadad scale w49x of 0-5, with one point being allocated for each aspect of good design, as follows: (i) study described as randomized: 1 point; (ii) adequate randomization technique: 1 point (if method inappropriate, deduct 1 point); (iii) subject blinding (i.e. control indistinguishable from acupuncture): 1 point; (iv) evaluator blinded to treatment: 1 point; (v) description of withdrawals and dropouts: 1 point.
White and Ernst report that no study achieved 5 points; only one achieved 4 points (good quality), six scored 3 (acceptable) and the others scored 2 or less (poor quality). All of the 'better' studies ( Table 2 ) had low numbers of subjects, suggesting low statistical power and a great risk of a type II error w50x.
According to White and Ernst, the trials by Petrie and Langley w20x and Petrie and Hazleman w21x scored two each on the Jadad scale. Ezzo et al. w11x, using the same system, scored the first of these as 1. We would argue that the second of these trials should have attained a score of 3. It was described as randomized, although the method of randomization was not stated. There was a clear description of withdrawals and a blinded assessor was used. The question of adequate patient blinding in this trial is also contentious. White and Ernst suggest that this trial had poor blinding. This cannot be substantiated from the original papers as, although the active and control treatments were different, both groups (allegedly) believed that they were receiving real treatment, although this was not formally tested. These anomalies highlight the problems of using an insensitive scoring regime in acupuncture trials where no convincing placebo exists and where the issue of therapist blinding similarly remains a problem. Indeed, inter-rater reliability for the Jadad scale has been tested formally w51x and shown to be poor, yielding a kappa score of 0.37-0.39. It also raises real and confusing issues in relation to the authors' interpretation of the Jadad scale and their subsequent individual scores for each study.
Internal vs external validity
Unfortunately, studies using the Jadad scale are perhaps prone to drawing the wrong conclusions if it is thought that this scale, of itself, is a reflection of the quality of the trial in general. Jadad et al. w49x suggested that assessing the validity of the primary studies is one of the key components of systematic reviews. In designing their scoring mechanism, they stated that their aim was to be able to assess the scientific 'quality, defined as the likelihood of the trial design to generate unbiased results and approach the therapeutic truth'. Although Jadad et al. did indeed use the word 'quality', it is important that their definition of quality and its inherent limitation is taken on board if this scoring mechanism is to be used. The emphasis must be on the generation of unbiased results in terms of randomization and blinding, as this is what their score measures and nothing else. It does not give any indication as to the overall quality or validity of a trial, neither does it give any general indication of 'therapeutic truth', unless such truth rests completely and solely in the ability of a trial to be unbiased. Jadad et al. specifically state that factors such as 'clinical relevance' are not assessed by their measure. As factors other than bias are deliberately omitted, it is of prime importance that those using this scale to assess 'quality' do not extrapolate their findings and suggest that a trial is good or bad simply by viewing the score. To do so would be to take a simplistic view of the research process and would certainly not be sensitive to many of the specific problems associated with acupuncture research. Jadad et al. tested their instrument by having 36 trials assessed by 14 raters. Whilst all of these were 'pain' trials, Jadad et al. do not give any indication as to the nature of these trials; for example, they may all have been pharmaceutical trials, which would not have highlighted some of the problems associated with manual treatments. Unfortunately, in their discussion Jadad et al. seem to move away from their previously rigid and well thought out aims of producing a biassensitive score when they suggest that the scoring mechanism would be useful for patients to evaluate the evidence presented to them by health professionals. Whilst researchers are trained and have experience in evaluating evidence and therefore must be expected to be able to understand the complexities and pitfalls involved in weighing up evidence presented in a trial, the average patient could easily be misled if it is suggested that the Jadad score provides a tool to assess the validity of presented evidence, as this implies a global reflection of quality and trial design. A trial with a high score on the Jadad system, whilst being unbiased in terms of randomization and blinding, might be subject to a multitude of other methodological problems and errors, which would cast doubt on the issue of internal validity. As has been pointed out, validity depends on much more than the proper conduct of the randomization process w52x. If a trial, and therefore a systematic review, is to be relevant, it must also have external validity and it must therefore be possible to extrapolate the results in a way that is meaningful for clinical practice. The treatment used must be pragmatic and the outcomes must be validated and relevant to the question being asked. If these important factors are not inherent within a scoring mechanism, they must at least be taken into consideration during the inclusionuexclusion process if they are to have any external validity. Failure to take these factors into account is a misrepresentation of the truth and of the underlying science.
There is a plethora of scoring mechanisms and guidance scales that can be employed to grade RCTs, and a cursory glance at the literature reveals at least 26 different scoring techniques w5, 51-75x. Some of these are very narrow in their scope and concentrate on a few items, e.g. three in the Jadad system, whereas others contain many more criteria, e.g. 34 items for a scale developed by Reisch et al. w72x. Moher et al. w76x have pointed out that when scales assign higher scores for double blinding, this 'automatically discriminates against trials in which masking may be inappropriate or impossible'. This would, of course, be particularly relevant to acupuncture trials, where the complexities of a treatment regime are fundamentally different to those found in pharmacological trials. Perhaps it would be more useful in this instance to use a scale which is more sensitive to the subject matter and takes these complexities into account. If scoring is to play an integral part in the overall process of a systematic review, then the choice of instrument must be made with thoughtful consideration for the subject matter. This in itself can be fraught with difficulties, as the choice of scoring mechanism can alter the outcome of the systematic review or meta-analysis. Juni et al. w48x conducted a study which examined 25 scoring scales, where they repeated a meta-analysis using these different scoring measures in order to assess whether the choice of scale affected the outcome of the meta-analysis. The metaanalysis they selected was one dealing with a comparison between standard heparin and low molecular weight heparin (LMWH) for the prevention of postoperative thrombosis. They calculated the median score for each trial (17 trials in total) and expressed this as a percentage of the total score for each system. This gave a very large spread of results, ranging from 38.5 to 82.9%, thus illustrating the large discrepancies between these scales. When trials were weighted for quality by each scale, they found that six scales showed that LMWH was not superior to standard heparin, whilst a further seven scales showed that it was superior. Therefore, depending on the scale chosen, the effect size could be manipulated to show either a positive or negative result. They further commented that trial quality could be affected by characteristics such as the setting, the characteristics of the patients and treatments, and that the incorporation of quality scores as weights lacks statistical or empirical justification. They concluded by suggesting that relevant methodological aspects should be identified and assessed individually.
Conclusion
It can be seen that, despite many trials, the question of the efficacy of acupuncture for the treatment of chronic mechanical neck pain remains unanswered. The feel of the state of knowledge within acupuncture research at the present moment was captured by Ernst and White w7x in their review, and their conclusions are summarized in Table 3 .
We feel that the only way forward in the search for answers in relation to the clinical effectiveness of acupuncture is not to re-examine existing trials in systematic reviews, as clearly there are too few trials of sufficient quality and homogeneity to be able to draw any conclusions at all and the strength of any systematic review will ultimately rely on the quality of the primary research on which it is based w77x. Instead, the focus must be on actually conducting more clinical trials. A good systematic review can only build on the foundations provided by well-conducted trials. If the trials do not exist or are of poor quality then it does not matter how many times they are reviewed-they will consistently fail to produce meaningful conclusions. Systematic reviews and meta-analysis are important tools as many people use these to gain an overall sense of how this therapy may be used and valued in clinical practice. Policy foundation for evidence-based practice guidelines, economic evaluations and research agendas may be based on this important area of research. But this, as in any other area of research, may be prone to flaws w78x. It therefore behoves those who conduct these reviews to do so responsibly and with sensitivity to the subject matter. They must use logical and defendable inclusion and exclusion criteria, some of which must include a careful and clinically relevant consideration of the treatment used. Any scoring system used must be able to differentiate between trials of good methodology (based on current clinical practice), which may have tackled these problems logically, and those that are simply biased and of poor quality. Lastly, it must be borne in mind that many 'scientific' principles are not cast in stone to be propounded as absolute truths but are open to interpretation and must be used with caution and updated in the light of further research. 
